Am J Transplant, Volume 20, Suppl 3 Archives - Page 13 of 223 - ATC Abstracts

2020 American Transplant Congress
Initial Case Series of Pure Laparoscopic Donor Hepatectomy in Cleveland Clinic
K. Sasaki, F. Aucejo, M. Fujiki, T. Diago Uso, B. Eghtesad, C. MIller, C. Quintini, K. Hashimoto, C. D. Kwon
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: Techniques for laparoscopic liver resection (LLR) have been developed over the two decades, and its advantage in less postoperative pain and early recovery are…
2020 American Transplant Congress
Frailty Assessment in Patients Undergoing Liver Transplant Evaluation: A Large Single Center Experience
H. Oduor, P. Mantry, L. Lesch, M. Alford, M. Pickle, M. Barnes, A. Habib, A. Mehta, A. Mejia, H. Nazario, M. Pagadala, V. Puri, Z. Vahora, J. Weinstein
The Liver Institute at Methodist Dallas, Dallas, TX
*Purpose: Frailty is a multi-component syndrome characterized by reduced physiologic reserve and functional decline. It is an independent predictor of poor post-transplant outcomes, including prolonged…
2020 American Transplant Congress
Single Center Experience of Valganciclovir and Adjunctive CMV IVIG for the Treatment of CMV Infection in Lung Transplant Recipients
A. A. Fernandez¹, N. Sinha², M. Loebe², J. Glaze², S. Manickavel², M. Fernandez², T. Pastrana², J. Simkins³, J. Camargo³, M. I. Morris³, L. Abbo³, Y. Natori³
¹Infectious Disease, University of Miami Jackson Memorial Hospital, Miami, FL, ²University of Miami Jackson Memorial Hospital, Miami, FL, ³Transplant Infectious Disease, University of Miami Jackson Memorial Hospital, Miami, FL
*Purpose: Cytomegalovirus(CMV) infection happens commonly and causes significant morbidity in lung transplant (LTx) recipients. The use of CMV hyperimmune globulin (CMVIg) as an adjunctive treatment…
2020 American Transplant Congress
Hepatitis C Antibody Seroconversion after Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients
U. A. Agbim¹, O. Cseprekal², M. Yazawa¹, M. Talwar¹, V. Balaraman¹, A. Bhalla¹, P. S. Podila³, B. Maliakkal¹, S. Nair¹, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN
*Purpose: We aimed to assess factors associated with hepatitis C virus (HCV) seroconversion among HCV seronegative kidney transplant candidates receiving HCV infected donor kidneys.*Methods: This…
2020 American Transplant Congress
Epstein-Barr Virus-Specific Cytotoxic T Lymphocyte Precursors (EBV-CTLp) after Tab-cel Correlates with Response & Survival in Rituximab Relapsing or Refractory Ebv⁺ Posttransplant Lymphoproliferative Disease (PTLD)
R. Shen¹, N. Guzman-Becerra¹, Y. Sun¹, F. Forozan¹, S. Prockop², E. Doubrovina², R. O'Reilly², X. Li¹, M. Hiremath³, L. Gamelin¹, W. Navarro¹, B. Aftab¹
¹Atara Biotherapeutics, Thousand Oaks, CA, ²Memorial Sloan Kettering Cancer Center, New York, NY, ³Atara Biotherapeutics, South San Francisco, CA
*Purpose: EBV+ PTLD is often a fatal disease. Tab-cel is an investigational off-the-shelf, allogeneic T-cell immunotherapy specific for EBV antigens. Functional in vivo expansion approximated…
2020 American Transplant Congress
Creating a Patient Website to Search for Transplant Centers: www.transplantcentersearch.org
C. R. Schaffhausen¹, S. Chu², M. Bruin³, A. Matas⁴, M. Hertz⁵, C. Martin⁵, J. Lake⁶, W. Kim⁷, S. Biggins⁸, J. J. Snyder⁹, B. L. Kasiske⁹, A. K. Israni¹⁰
¹Hennepin Heathcare Research Institute (HHRI), Minneapolis, MN, ²College of Design, University of Minnesota (UMN), Saint Paul, MN, ³College of Design, UMN, Saint Paul, MN, ⁴Department of Surgery, UMN, Minneapolis, MN, ⁵Department of Medicine, UMN, Minneapolis, MN, ⁶Division of Gastroenterology, Hepatology, and Nutrition, UMN, Minneapolis, MN, ⁷Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, ⁸Division of Hepatology, University of Washington, Seattle, WA, ⁹Scientific Registry of Transplant Recipients, Minneapolis, MN, ¹⁰Department of Medicine, HHRI, UMN, Minneapolis, MN
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) data was used to create a website with a tailored decision guide to help inform patient decisions…
2020 American Transplant Congress
Ex Vivo Pumping Through an OPO’s Eyes
A. L. Friedman, E. Marquez
LiveOnNY, New York, NY
*Purpose: A single, large organ procurement organization (OPO) sought to document the use of extra-renal ex vivo pumping in the management of the deceased donor…
2020 American Transplant Congress
Vascularized Composite Allograft (VCA) Waiting List and Transplant Trends in the U.S
J. Wainright¹, C. Wholley², W. Cherikh¹, D. Klassen³
¹Research, UNOS, Richmond, VA, ²Policy and Community Relations, UNOS, Richmond, VA, ³Chief Medical Officer, UNOS, Richmond, VA
*Purpose: Vascularized Composite Allograft (VCA) transplantation is a rapidly changing field. *Methods: Since the Organ Procurement and Transplantation Network (OPTN) implemented the VCA waiting list…
2020 American Transplant Congress
A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience
Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu
Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
*Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…
2020 American Transplant Congress
The Use of Allosure Donor Derived Cell-Free DNA in a Community Based Kidney Transplant Program
V. Scantlebury, S. Gilibert, C. Sentman, H. Chang-DeGuzman, S. Swanson
Kidney Transplantation, Christiana Care Hospital, Newark, DE
*Purpose: Donor derived cell-free DNA (dd-cfDNA) has emerged as a marker of kidney allograft injury. Beginning in 2019, the dd-cfDNA monitoring has been introduced as…